Our Portfolio

Over $100mm invested into more than 85 startups since 2020.

2A Biosciences
First psychedelic drug discovery and development company devoted to solely preventing and treating inflammatory diseases, starting with dermatological diseases, via 5HT2A receptor activation.

Aeon
Aeon combines warfighter experience with world-class engineering to build lethal weapon systems at scale.

Affect Therapeutics
Affect is the first digital therapeutics drug addiction app & program addressing the massive stimulant addiction epidemic. Affect uses an evidence-based and rewards-driven curriculum to drive real behavioral change and replace expensive drug addiction treatment. By combining a digital therapeutic app with an integrated care team, the Affect program delivers real-time, data-driven improvements in treatment, driving outcomes and lowering healthcare costs.

Allen Control Systems
Allen Control Systems is a robotics defense company purpose-built to deliver advanced robotic capabilities to fill modernization demands across the defense industry and national security communities.

Alto Neuroscience
Alto Neuroscience is developing a new generation of psychiatric drugs that are more effective by virtue of personalization, achieved by integrating biomarkers into psychiatric drug development.
IPO

Alto Pharmacy
The Company is a digital pharmacy that delivers medications to patients at home. Their goal is not simply to distribute prescription medications but to improve patients’ health outcomes and their quality of life and to make those improvements accessible to everybody.

AmyriAD
AmyriAD has a phase 3 drug candidate that has demonstrated symptom improving effects via combination therapy against Alzheimer’s Disease (AD).

Applied Cognition
Applied Cognition is a healthcare innovation company developing treatments for age-related declines in cognitive function.

AptiHealth
AptiHealth is a behavioral health engagement solution connecting medical providers, behavioral health specialists, and patients through a centralized digital offering that has demonstrated market-leading improvements in health outcomes and cost reductions.

Atai Life Sciences
Atai is pioneering the development of more effective and potentially disease-modifying mental health treatments.
IPO

Beckley Psytech
Addressing neurological and psychiatric disorders through the novel application of psychedelic medicines.

Bionaut Labs
A Bionaut is a magnetically controlled micro robot designed to travel within the body to deliver therapeutic payloads throughout the Central Nervous System (CNS).